A Study to Evaluate the Incidence and Clinical Characteristics of Interstitial Lung Disease (ILD) Associated with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR-TKIs) Gefitinib or Erlotinib in Taiwanese Patients with Adavanced Non Small Cell Lung Cancer (NSCLC)
Latest Information Update: 19 Dec 2015